Inspire Medical Systems Swings to Q3 Net Loss of $24.4 Million

PUBT · 1d ago
Inspire Medical Systems Swings to Q3 Net Loss of $24.4 Million
  • Inspire Medical Systems swung to a third-quarter 2026 net loss of $24.4 million from a year-earlier profit of $9.93 million.
  • Revenue fell 8% year-over-year to $206.7 million, primarily due to U.S. coding and reimbursement challenges.
  • New Category I CPT codes covering single-lead hypoglossal nerve stimulation, including Inspire V, take effect January 1, 2028.
  • Management plans for a return to growth in 2027.
  • Full-year 2026 revenue guidance narrowed to $850 million–$860 million from $835 million–$875 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inspire Medical Systems Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611021628PRIMZONEFULLFEED9868509) on November 02, 2026, and is solely responsible for the information contained therein.